دورية أكاديمية
Transcription factor induction of vascular blood stem cell niches in vivo.
| العنوان: | Transcription factor induction of vascular blood stem cell niches in vivo. |
|---|---|
| المؤلفون: | Hagedorn EJ; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA; Section of Hematology and Medical Oncology and Center for Regenerative Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA., Perlin JR; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA., Freeman RJ; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA., Wattrus SJ; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA., Han T; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA., Mao C; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA., Kim JW; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA., Fernández-Maestre I; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA., Daily ML; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA., D'Amato C; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA., Fairchild MJ; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA., Riquelme R; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA., Li B; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA., Ragoonanan DAVE; Section of Hematology and Medical Oncology and Center for Regenerative Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA., Enkhbayar K; Section of Hematology and Medical Oncology and Center for Regenerative Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA., Henault EL; Section of Hematology and Medical Oncology and Center for Regenerative Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA., Wang HG; Section of Hematology and Medical Oncology and Center for Regenerative Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA., Redfield SE; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA., Collins SH; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA., Lichtig A; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA., Yang S; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA., Zhou Y; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA., Kunar B; Ansary Stem Cell Institute, Division of Regenerative Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Gomez-Salinero JM; Ansary Stem Cell Institute, Division of Regenerative Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Dinh TT; Veterans Affairs Palo Alto Health Care System, The Palo Alto Veterans Institute for Research and the Department of Pathology, Stanford University, Stanford, CA, USA., Pan J; Veterans Affairs Palo Alto Health Care System, The Palo Alto Veterans Institute for Research and the Department of Pathology, Stanford University, Stanford, CA, USA., Holler K; Berlin Institute for Medical Systems Biology, Max Delbruck Center for Molecular Medicine, Berlin, Germany., Feldman HA; Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, MA, USA., Butcher EC; Veterans Affairs Palo Alto Health Care System, The Palo Alto Veterans Institute for Research and the Department of Pathology, Stanford University, Stanford, CA, USA., van Oudenaarden A; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands., Rafii S; Ansary Stem Cell Institute, Division of Regenerative Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Junker JP; Berlin Institute for Medical Systems Biology, Max Delbruck Center for Molecular Medicine, Berlin, Germany., Zon LI; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA, USA. Electronic address: zon@enders.tch.harvard.edu. |
| المصدر: | Developmental cell [Dev Cell] 2023 Jun 19; Vol. 58 (12), pp. 1037-1051.e4. Date of Electronic Publication: 2023 Apr 28. |
| نوع المنشور: | Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Cell Press Country of Publication: United States NLM ID: 101120028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1551 (Electronic) Linking ISSN: 15345807 NLM ISO Abbreviation: Dev Cell Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Cambridge, Mass. : Cell Press, c2001- |
| مواضيع طبية MeSH: | Stem Cell Niche* , Transcription Factors*/genetics , Transcription Factors*/metabolism, Animals ; Endothelial Cells/metabolism ; Zebrafish/genetics ; Zebrafish/metabolism ; Gene Expression Regulation |
| مستخلص: | The hematopoietic niche is a supportive microenvironment composed of distinct cell types, including specialized vascular endothelial cells that directly interact with hematopoietic stem and progenitor cells (HSPCs). The molecular factors that specify niche endothelial cells and orchestrate HSPC homeostasis remain largely unknown. Using multi-dimensional gene expression and chromatin accessibility analyses in zebrafish, we define a conserved gene expression signature and cis-regulatory landscape that are unique to sinusoidal endothelial cells in the HSPC niche. Using enhancer mutagenesis and transcription factor overexpression, we elucidate a transcriptional code that involves members of the Ets, Sox, and nuclear hormone receptor families and is sufficient to induce ectopic niche endothelial cells that associate with mesenchymal stromal cells and support the recruitment, maintenance, and division of HSPCs in vivo. These studies set forth an approach for generating synthetic HSPC niches, in vitro or in vivo, and for effective therapies to modulate the endogenous niche. Competing Interests: Declaration of interests L.I.Z. is a founder and stockholder of Fate Therapeutics, CAMP4 Therapeutics, and Scholar Rock. He is a consultant for Celularity. (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.) |
| References: | Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W249-52. (PMID: 15215389) Dev Cell. 2017 Aug 21;42(4):349-362.e4. (PMID: 28803829) Nat Commun. 2015 Sep 28;6:8375. (PMID: 26411530) Cell Rep. 2019 Apr 30;27(5):1567-1578.e5. (PMID: 31042481) Cell Stem Cell. 2009 Mar 6;4(3):263-74. (PMID: 19265665) Cell. 2014 Oct 23;159(3):662-75. (PMID: 25417113) Dev Dyn. 2003 May;227(1):14-26. (PMID: 12701095) J Mol Med (Berl). 2017 Aug;95(8):809-819. (PMID: 28702683) Development. 2011 Jan;138(1):169-77. (PMID: 21138979) Nature. 2009 Jan 22;457(7228):490-4. (PMID: 19078959) ACS Nano. 2018 Mar 27;12(3):2138-2150. (PMID: 29320626) Blood. 2005 Dec 1;106(12):3803-10. (PMID: 16099879) Stem Cell Reports. 2017 May 9;8(5):1226-1241. (PMID: 28416284) Blood. 2016 Sep 8;128(10):1336-45. (PMID: 27402973) Nat Biotechnol. 2010 May;28(5):511-5. (PMID: 20436464) Nature. 2019 May;569(7755):222-228. (PMID: 30971824) Nat Cell Biol. 2011 Jun;13(6):686-92. (PMID: 21572418) Science. 2016 Jan 8;351(6269):176-80. (PMID: 26634440) Nat Commun. 2018 Jun 22;9(1):2449. (PMID: 29934585) Cell. 2002 May 31;109(5):625-37. (PMID: 12062105) Cell Stem Cell. 2010 Mar 5;6(3):251-64. (PMID: 20207228) PLoS Biol. 2006 Jan;4(1):e10. (PMID: 16336046) Biochem Biophys Res Commun. 2011 Jun 24;410(1):121-6. (PMID: 21641336) Dev Biol. 2014 Jun 15;390(2):116-25. (PMID: 24699544) Nat Cell Biol. 2019 May;21(5):560-567. (PMID: 30988422) Dev Comp Immunol. 1979 Winter;3(1):55-65. (PMID: 437237) Cell. 2005 Jul 1;121(7):1109-21. (PMID: 15989959) Nature. 2013 Mar 14;495(7440):231-5. (PMID: 23434755) Cell. 1996 Feb 23;84(4):563-74. (PMID: 8598043) Exp Cell Res. 2000 Apr 10;256(1):282-90. (PMID: 10739675) Cell. 2015 Jan 15;160(1-2):241-52. (PMID: 25594182) Nat Commun. 2019 Dec 13;10(1):5705. (PMID: 31836710) J Blood Med. 2010;1:13-9. (PMID: 22282679) Proc Natl Acad Sci U S A. 2021 Apr 27;118(17):. (PMID: 33875597) J Exp Med. 2001 Oct 15;194(8):1033-42. (PMID: 11602634) Nat Protoc. 2017 Jan;12(1):44-73. (PMID: 27929523) Nature. 2013 Oct 31;502(7473):637-43. (PMID: 24107994) Science. 2019 Dec 6;366(6470):1218-1225. (PMID: 31672914) Cell. 2008 Feb 22;132(4):631-44. (PMID: 18295580) Blood. 2006 May 1;107(9):3764-71. (PMID: 16439683) Blood. 2011 Jan 27;117(4):e49-56. (PMID: 21084707) Blood. 2011 Jul 21;118(3):766-74. (PMID: 21622651) Development. 2012 Jun;139(11):1978-86. (PMID: 22513376) Nature. 2013 Mar 14;495(7440):227-30. (PMID: 23434756) Genes Dev. 2008 Mar 15;22(6):734-9. (PMID: 18347092) Nature. 2018 Dec;564(7734):119-124. (PMID: 30455424) Blood. 2008 Mar 1;111(5):2657-66. (PMID: 18094332) Nat Med. 2004 Jan;10(1):64-71. (PMID: 14702636) PLoS Biol. 2013;11(6):e1001590. (PMID: 23853546) Bioinformatics. 2009 May 1;25(9):1105-11. (PMID: 19289445) Nat Methods. 2013 Dec;10(12):1213-8. (PMID: 24097267) Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):911-2. (PMID: 12740225) Nat Protoc. 2008;3(1):59-69. (PMID: 18193022) Cell. 2019 Jun 13;177(7):1915-1932.e16. (PMID: 31130381) Genome Biol. 2008;9(9):R137. (PMID: 18798982) Immunity. 2018 Apr 17;48(4):632-648. (PMID: 29669248) Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):160-5. (PMID: 25540418) Cell. 2007 Oct 19;131(2):324-36. (PMID: 17956733) Nat Methods. 2012 Mar 04;9(4):357-9. (PMID: 22388286) J Leukoc Biol. 2007 Nov;82(5):1156-65. (PMID: 17675564) J Exp Med. 2017 Oct 2;214(10):2875-2887. (PMID: 28878000) Mol Cell. 2010 May 28;38(4):576-89. (PMID: 20513432) Physiol Genomics. 2008 Apr 22;33(2):148-58. (PMID: 18230668) J Exp Med. 2017 Apr 3;214(4):1011-1027. (PMID: 28351983) Nature. 2016 Apr 21;532(7599):323-8. (PMID: 27074509) Cell. 2008 Dec 12;135(6):1053-64. (PMID: 19070576) PLoS One. 2014 Aug 26;9(8):e105939. (PMID: 25157918) Immunity. 2006 Dec;25(6):963-75. (PMID: 17157041) Eur J Immunol. 2003 Mar;33(3):815-24. (PMID: 12616502) Proc Natl Acad Sci U S A. 2021 Apr 6;118(14):. (PMID: 33785593) Cell. 2012 Oct 26;151(3):559-75. (PMID: 23084400) Nature. 2012 Jan 25;481(7382):457-62. (PMID: 22281595) Nat Med. 2012 Nov;18(11):1651-7. (PMID: 23086476) Immunity. 2006 Dec;25(6):977-88. (PMID: 17174120) |
| معلومات مُعتمدة: | T32 HL007574 United States HL NHLBI NIH HHS; K01 DK111790 United States DK NIDDK NIH HHS; U01 HL100001 United States HL NHLBI NIH HHS; T32 HL098049 United States HL NHLBI NIH HHS; P01 HL131477 United States HL NHLBI NIH HHS; RC2 DK120535 United States DK NIDDK NIH HHS; T32 HD060600 United States HD NICHD NIH HHS; R01 AI130471 United States AI NIAID NIH HHS; U01 HL134812 United States HL NHLBI NIH HHS; R01 HL144780 United States HL NHLBI NIH HHS; I01 BX002919 United States BX BLRD VA; U54 DK110805 United States DK NIDDK NIH HHS; R24 DK092760 United States DK NIDDK NIH HHS |
| فهرسة مساهمة: | Keywords: blood stem cell niche; hematopoietic development; niche endothelial cells; reprogramming; vascular endothelium; zebrafish |
| المشرفين على المادة: | 0 (Transcription Factors) |
| تواريخ الأحداث: | Date Created: 20230429 Date Completed: 20230622 Latest Revision: 20240620 |
| رمز التحديث: | 20240620 |
| مُعرف محوري في PubMed: | PMC10330626 |
| DOI: | 10.1016/j.devcel.2023.04.007 |
| PMID: | 37119815 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1878-1551 |
|---|---|
| DOI: | 10.1016/j.devcel.2023.04.007 |